The impact of inhaler device regimen in patients with asthma or COPD
File(s)
Published version
Author(s)
Type
Journal Article
Abstract
Many inhaler devices with varying handling requirements for optimal use are available for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Patients may be prescribed different device types for reliever and maintenance medications, which may lead to confusion and suboptimal device use. We aimed to understand whether simplifying inhaler regimens by employing a single device type in patients who use multiple devices or prescribing a device with which a patient was already experienced could improve clinical and economic outcomes in asthma and COPD management. A targeted literature search was performed and additional articles were identified through hand searching citations within screened publications. A total of 114 articles were included in the final review. Findings suggest that simplifying inhaler regimens by applying the same type of inhaler for concomitant inhaled medications over time minimizes device misuse, leading to improved clinical outcomes and reduced health care use in patients with asthma or COPD. Physicians should consider a patient's suitability for a device and training needs when prescribing an inhaled medication and before changing the medication type or dose, especially when suboptimal treatment outcomes are observed. Further research is required to determine whether consistent use of the same device type is associated with better treatment adherence and persistence in patients with asthma or COPD. Nevertheless, this literature review identified clinical benefits and reduced health care use with simplified inhaler regimens.
Date Issued
2021-08
Date Acceptance
2021-04-09
Citation
Journal of Allergy and Clinical Immunology: In Practice, 2021, 9 (8), pp.3033-3040.e1
ISSN
2213-2198
Publisher
Elsevier
Start Page
3033
End Page
3040.e1
Journal / Book Title
Journal of Allergy and Clinical Immunology: In Practice
Volume
9
Issue
8
Copyright Statement
© 2021 The Authors. Published by Elsevier Inc. on behalf of the American Academy
of Allergy, Asthma & Immunology. This is an open access article under the CC
BY license (http://creativecommons.org/licenses/by/4.0/).
https://doi.org/10.1016/j.jaip.2021.04.024
of Allergy, Asthma & Immunology. This is an open access article under the CC
BY license (http://creativecommons.org/licenses/by/4.0/).
https://doi.org/10.1016/j.jaip.2021.04.024
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/33901714
PII: S2213-2198(21)00464-5
Subjects
Aerosol devices
Asthma
Chronic obstructive pulmonary disease
Clinical outcomes
Economic outcomes
Inhalation therapy
Therapeutic regimen
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2021-04-24